This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Pierre Barratt
Vice President, Strategy & Program Management at Codexis
Speaker

Profile

Pierre Barratt is the VP, Strategy & Program Management at Codexis for the ECO Synthesis® Manufacturing Platform. Previously, Pierre spent 12 years at LGC, culminating as Sr. Director at LGC Axolabs US, overseeing GMP API Manufacturing, MSAT, and Process & Analytical Development for nucleic acid therapeutics. Earlier roles at LGC focused on operational management across analytical cGMP sites for small‑molecule and peptide drug development. In 1999 Pierre began his career at Pfizer, where he spent 13 years developing, validating, and transferring physicochemical methods for late phase and commercial manufacturing also serving as an SME for CMC dossier authorship.

Agenda Sessions

  • ECO Synthesis® Manufacturing Platform Enables In-Process Control with Analytical Monitoring after Each Cycle

    12:40